UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.CFORM 8-K Current Report

First Page		Document Content
Date: 2015-12-18 01:40:12 Medical research Health Clinical research Pharmaceutical industry Ampakines Clinical pharmacology Cortex Pharmaceuticals Food and Drug Administration Clinical trial		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.CFORM 8-K Current Report Add to Reading List Source URL: compliance-sec.com Download Document from Source Website File Size: 194,26 KB Share Document on Facebook

$Submission Proof - D:\Dropbox (SEC Compliance)\2016 OPERATIONS\2016 EDGAR\03_March\Respirerx Pharmaceuticals I... Page 3 of 118 form10-k.htm 10-K$	Submission Proof - D:\Dropbox (SEC Compliance)\2016 OPERATIONS\2016 EDGAR\03_March\Respirerx Pharmaceuticals I... Page 3 of 118 form10-k.htm 10-K DocID: 1rkMs - View Document
	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.CFORM 8-K Current Report DocID: 1rkLO - View Document
	Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors; Expands Board to Five Members James E. Sapirstein and Kathryn MacFarlane join the Board of Directors DocID: 1m1QS - View Document
	Cortex Pharmaceuticals, Inc. Files December 31, 2014 Annual Report on Form 10-K; Provides Update on Current Status and Activities Company Focusing on Strategic Initiatives DocID: 1lSog - View Document
	EXHIBIT, 8:48 AM EXex99-1.htm EXHIBIT 99.1 DocID: 1lqmB - View Document